We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJAQ
5126
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
$607K ﹤0.01%
61,598
+25,000
+68% +$245K
GGGVU
5127
DELISTED
G3 VRM Acquisition Corp. Units
GGGVU
$607K ﹤0.01%
+59,551
New +$602K
YAC
5128
CALL
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$607K ﹤0.01%
572,399
-88,803
-13% -$877K
THMAU
5129
DELISTED
Thimble Point Acquisition Corp. Unit
THMAU
$607K ﹤0.01%
60,000
-462,115
-89% -$4.73M
HSTM icon
5130
HealthStream
HSTM
$819M
$606K ﹤0.01%
21,197
+6,282
+42% +$183K
INVX
5131
Innovex International
INVX
$1.96B
$606K ﹤0.01%
24,067
+13,272
+123% +$353K
EPHYW
5132
CALL
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$605K ﹤0.01%
687,329
+91,257
+15% +$94.7K
CVSA
5133
Covista Inc
CVSA
$4.25B
$604K ﹤0.01%
15,983
-105,307
-87% -$3.91M
CNSL
5134
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$603K ﹤0.01%
65,619
+50,953
+347% +$454K
DMYI.WS
5135
CALL
DELISTED
dMY Technology Group, Inc. III Redeemable warrants, each whole warrant exercisable for one share of
DMYI.WS
$603K ﹤0.01%
174,401
LPG icon
5136
Dorian LPG
LPG
$2.03B
$602K ﹤0.01%
48,472
-65,684
-58% -$820K
YARW
5137
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$601K ﹤0.01%
480
-275
-36% -$533K
GGPI
5138
CALL
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
$601K ﹤0.01%
+58,800
New +$585K
BGRYW
5139
CALL
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
$599K ﹤0.01%
494,649
+121,159
+32% +$169K
RAM
5140
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
$599K ﹤0.01%
+60,000
New +$591K
IRNT
5141
DELISTED
IronNet, Inc.
IRNT
$598K ﹤0.01%
35,084
-594,079
-94% -$8.74M
PEARW
5142
CALL
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$598K ﹤0.01%
629,149
+29,433
+5% +$30.7K
BSN
5143
CALL
DELISTED
Broadstone Acquisition Corp.
BSN
$598K ﹤0.01%
553,489
STON
5144
DELISTED
StoneMor Inc.
STON
$595K ﹤0.01%
+240,895
New +$618K
TEKK
5145
CALL
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
$595K ﹤0.01%
668,927
-11,200
-2% -$109K
OPRA
5146
Opera Ltd
OPRA
$1.69B
$594K ﹤0.01%
67,137
+3,666
+6% +$35.6K
CBMB
5147
DELISTED
CBM Bancorp, Inc.
CBMB
$594K ﹤0.01%
36,648
-79
-0.2% -$1.2K
MAQC
5148
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$592K ﹤0.01%
59,154
+40,000
+209% +$397K
TGTX icon
5149
TG Therapeutics
TGTX
$7.96B
$591K ﹤0.01%
17,758
-101,456
-85% -$3.14M
GLSI icon
5150
Greenwich LifeSciences
GLSI
$198M
$590K ﹤0.01%
+15,098
New +$631K

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.